Abstract
ObjectiveTo examine mortality and morbidity patterns before and after premalignancy diagnosis in individuals with monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL) and compare their secondary healthcare...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have